Marius Keller

Targeted glycan degradation potentiates the anticancer immune response in vivo

CD8⁺ cytotoxic and FoxP3⁺ regulatory T lymphocytes serve as prognostic factors in breast cancer.

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer